Showing results (11-20 of 194) with videos related to
Sort By:
Pageof 20
Clinical Reviews in Allergy & Immunology|January 29, 2010
Cyclophosphamide and lupus nephritis: when, how, for how long?Stella Ntali, George Bertsias, Dimitrios T BoumpasCurrent Opinion in Rheumatology|June 6, 2008
Spinal infections: evolving conceptsIrene S Kourbeti, Sotirios Tsiodras, Dimitrios T BoumpasCurrent Opinion in Rheumatology|July 10, 2013
Pathogenesis and treatment of CNS lupusAntonis Fanouriakis, Dimitrios T Boumpas, George K BertsiasExpert Review of Clinical Pharmacology|November 26, 2011
Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosusAntonis Fanouriakis, Dimitrios T Boumpas, George K BertsiasArthritis Research & Therapy|May 22, 2008
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implicationsProdromos I Sidiropoulos, Stylianos A Karvounaris, Dimitrios T BoumpasEuropean Journal of Clinical Investigation|August 2, 2013
Gene expression and regulation in systemic lupus erythematosusEleni A Frangou, George K Bertsias, Dimitrios T BoumpasCritical Reviews in Clinical Laboratory Sciences|June 15, 2007
Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving conceptsAmalia Raptopoulou, Prodromos Sidiropoulos, Maria Katsouraki, et al.Modern Rheumatology|May 16, 2012
Recent progress in the treatment of lupus nephritisAntonis Fanouriakis, Eleni Krasoudaki, Michail Tzanakakis, et al.Cells|August 25, 2019
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral AgentAlessia Alunno, Ivan Padjen, Antonis Fanouriakis, et al.Expert Opinion on Pharmacotherapy|August 2, 2008
Pharmacotherapy of lupus nephritis: time for a consensus?Garyfallia Perysinaki, Simeon Panagiotakis, George Bertsias, et al.Pageof 20